|
产品描述
|
Certainly! Here is a refined and detailed product information guide for PepMix™ EBV (EBNA1), covering the aspects of Storage, Product Description, Key Features, What's Included, and Applications:
---
PepMix™ EBV (EBNA1) Product Information
Storage
- Temperature: Store at -20°C or lower.
- Stability: Avoid repeated freeze-thaw cycles. Once reconstituted, aliquot and store at -80°C to maintain integrity.
- Shelf Life: Up to 12 months if stored correctly. Check expiration date on the package for specific details.
- Handling Precautions: Ensure that the product is kept in a tightly sealed container to prevent contamination and moisture uptake.
Product Description
PepMix™ EBV (EBNA1) is a specialized peptide pool designed for use in immunological assays, particularly those focusing on Epstein-Barr Virus (EBV) research. EBNA1, a nuclear antigen of EBV, is crucial for the maintenance and replication of the virus within the host cells. This product consists of overlapping peptides that cover the entire sequence of the EBNA1 protein, facilitating comprehensive immune response studies.
Key Features
- High Purity: Synthesized using high-quality peptides to ensure consistent performance.
- Comprehensive Coverage: Includes overlapping peptides to represent the entire EBNA1 protein sequence, allowing for thorough epitope mapping.
- Versatile: Suitable for various immunological assays, including ELISPOT, flow cytometry, and T-cell activation studies.
- Reliable Performance: Batch-tested for consistency and effectiveness in stimulating immune responses.
What's Included
- PepMix™ EBV (EBNA1) Peptide Pool: Provided in a lyophilized form for ease of storage and handling.
- Certificate of Analysis: Details on peptide composition, purity, and batch-specific information.
- Product Insert: Instructions for reconstitution and recommended assay protocols.
Applications
- Immunological Assays: Ideal for use in ELISPOT, ELISA, and flow cytometry for detection and quantification of EBV-specific immune responses.
- Vaccine Research: Useful in the development and testing of EBV vaccines by assessing T-cell responses.
- Cancer Research: Applicable in studies related to EBV-associated malignancies, such as nasopharyngeal carcinoma and Hodgkin's lymphoma.
- Immunotherapy Development: Can be utilized in the development of T-cell-based immunotherapies targeting EBV-related diseases.
---
This information is designed to provide a comprehensive overview of PepMix™ EBV (EBNA1), ensuring users have the necessary details to effectively utilize the product in their research and applications.
|